DFE Pharma, a world leader in providing essential excipients for inhalation and oral solid dose applications for decades, has expanded its presence into the biopharmaceutical market.

Discover our BioHale® excipients for biologics to stabilize biopharmaceutical formulations, BioHale®Sucrose and BioHale Trehalose®, and benefit from:

- Uncompromised quality

- cGMP and FDA inspected manufacturing facility o Highest purity of excipients with very low endotoxin level

- Multi-compendial compliance (Ph. Eur., USP-NF, JP, ChP)

- Expert support

• Technical expertise
• Excipient information package available
• Quality and regulatory support

- Security of supply

- Local stocks

- Capacity to adapt to volatile demand

- Business Continuity Plan in place

In addition, we offer a purification step integrated into manufacturing process to enhance the product quality and consistency, strengthening supply chain security as product quality is not affected by raw material variations.

To learn more please visit https://dfepharma.com/